SCHEMBL29483353

SCHEMBL29483353

CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)NC(CO)(CO)CO)C(C)C)C(=O)NCc1ccccn1

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 13/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ditekiren SCHEMBL30671592 0.92 REN (0.84) REN
Ditekiren SCHEMBL122368 0.83 REN (1.00) REN
SCHEMBL7351443 0.72 REN (0.64) REN
SCHEMBL9755311 0.69 REN (0.67) REN
SCHEMBL10777425 0.68 REN (0.64) REN
SCHEMBL9755323 0.68 REN (0.57) REN
SCHEMBL14008234 0.67 REN (0.49) REN
SCHEMBL29448209 0.67 REN (0.66) REN
SCHEMBL7335814 0.66 REN (0.71) REN
SCHEMBL11013919 0.66 REN (0.66) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11273172-B2 Synergistic combination of oligonucleotides and chemotherapeutic for treating cancer THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-03-15 — — US disclosed
Send feedback